Synopsis
Synopsis
0
KDMF
0
VMF
0
Listed Dossiers
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Darob
2. Mj 1999
3. Mj-1999
4. Mj1999
5. Sotalol
6. Sotalol Monohydrochloride
1. 959-24-0
2. Sotalol Hcl
3. Betapace
4. Betapace Af
5. Sotalex
6. Sotacor
7. Sorine
8. Mj 1999
9. Sotalol (hydrochloride)
10. Sotylize
11. Darob
12. Mead Johnson 1999
13. Sotalol.hcl
14. (+/-)-sotalol Hydrochloride
15. Sotalol Monohydrochloride
16. Betapace (tn)
17. Sotalol (betapace)
18. Mj-1999
19. 4'-(1-hydroxy-2-(isopropylamino)ethyl)methanesulfonanilide Monohydrochloride
20. Isopropylaminohydroxyethylmethanesulfonanilide Hydrochloride
21. N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide;hydrochloride
22. Nsc-337251
23. Nsc-760358
24. N-isopropyl-beta-(4-methanesulfonamidophenyl)ethanolamine Hydrochloride
25. Hec37c70xx
26. Chebi:9207
27. 4-(2-isopropylamino-1-hydroxyaethyl)methanesulfonailid Hydrochlorid
28. Dl-mj-1999
29. N-[4-[1-hydroxy-2-(isopropylamino)ethyl]phenyl]methanesulfonamide Hydrochloride
30. 959-24-0 (hcl)
31. Ncgc00094337-02
32. Berlex
33. Dsstox_cid_1278
34. N-(4-(1-hydroxy-2-(isopropylamino)ethyl)phenyl)methanesulfonamide Hydrochloride
35. Dsstox_rid_76054
36. Methanesulfonamide, N-(4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)-, Monohydrochloride
37. N-(4-{1-hydroxy-2-[(1-methylethyl)amino]ethyl}phenyl)methanesulfonamide Hydrochloride
38. N-{4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamide Hydrochloride
39. Dsstox_gsid_21278
40. Sotalol Hydrochloride 100 Microg/ml In Acetonitrile
41. N-(2-hydroxy-2-{4-[(methylsulfonyl)amino]phenyl}ethyl)propan-2-aminium Chloride
42. N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide Hydrochloride
43. 366-80-3
44. Methanesulfonamide, N-[4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]phenyl]-, Hydrochloride (1:2)
45. Smr000326828
46. Sotalol Hydrochloride [usan]
47. Sr-01000076116
48. Einecs 213-496-0
49. Unii-hec37c70xx
50. 4'-(1-hydroxy-2-isopropylaminoethyl)methanesulphonanilide Hydrochloride
51. 4'-[1-hydroxy-2-(isopropylamino)ethyl]methanesulfonanilide Monohydrochloride
52. N-(4-[1-hydroxy-2-(isopropylamino)ethyl]phenyl)methanesulfonamide Hydrochloride
53. N-[4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]phenyl]methanesulfonamide Hydrochloride
54. Sotalol, Hcl
55. Sotalol Hydrochloride [usan:usp]
56. Mfcd00242937
57. Sorine (tn)
58. Cpd000326828
59. Mj 1999 Hydrochloride
60. (y)-sotalol Hydrochloride
61. Cas-959-24-0
62. (?)-sotalol Hydrochloride
63. 4-(2-isopropylamino-1-hydroxyaethyl)methanesulfonailid Hydrochlorid [german]
64. Chembl1700
65. Sotalol Hydrochloride- Bio-x
66. Mls000758296
67. Mls000859969
68. Mls001401380
69. Mls002222318
70. Schembl118761
71. Dtxsid8021278
72. Sotalol Hydrochloride (jan/usp)
73. Hms1571a13
74. Pharmakon1600-01506043
75. Sotalol Hydrochloride [mi]
76. Sotalol Hydrochloride [jan]
77. Bcp02975
78. Hy-b0437
79. Tox21_111267
80. Tox21_200127
81. Tox21_501055
82. Nsc337251
83. Nsc760358
84. S2509
85. Sotalol Hydrochloride [vandf]
86. Sotalol Hydrochloride [mart.]
87. Akos015888287
88. Sotalol Hydrochloride [usp-rs]
89. Sotalol Hydrochloride [who-dd]
90. Ac-3541
91. Ccg-100907
92. Ccg-213603
93. Lp01055
94. Nc00157
95. Nsc 337251
96. Nsc 760358
97. Wln: Ws1&mr Dyq1my1&1 &gh
98. Methanesulfonanilide, 4'-(1-hydroxy-2-(isopropylamino)ethyl)-, Monohydrochloride
99. Ncgc00094337-01
100. Ncgc00094337-03
101. Ncgc00257681-01
102. Ncgc00261740-01
103. As-13017
104. Bs164418
105. Bcp0726000245
106. Sotalol Hydrochloride [orange Book]
107. Sotalol Hydrochloride [ep Monograph]
108. Eu-0101055
109. Ft-0603531
110. Sotalol Hydrochloride [usp Monograph]
111. Sw197352-4
112. ( Inverted Question Mark)-sotalol Hydrochloride
113. D01026
114. F21235
115. S 0278
116. Sotylize Component Sotalol Hydrochloride
117. (+/-)-sotalol Hydrochloride, Analytical Standard
118. 959s240
119. A845501
120. Sotalol Hydrochloride Component Of Sotylize
121. Q-201730
122. Sr-01000076116-2
123. Sr-01000076116-3
124. Sr-01000076116-8
125. (+/-)-sotalol Hydrochloride, >=98% (tlc), Powder
126. Q27108309
127. Sotalol Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
128. [(isopropylamino)hydroxyethyl]methanesulfonanilide Hydrochloride
129. 4'-[1-hydroxy-2-(isopropylamino)ethyl]methanesulfonanilide Hydrochloride
130. 4'-[2-(isopropylamino)-1-hydroxyethyl]methanesulfonanilide Hydrochloride
131. 4'-[2-(isopropylamino)-1-hydroxyethyl]methanesulfonanilide Monohydrochloride
132. 4-[2-(isopropylamine)-1-hydroxyethyl]methanesulfonanilide Hydrochloride
133. N-isopropyl-.beta.-(4-methanesulfonamidophenyl)ethanolamine Hydrochloride
134. P-[1-hydroxy-2-(isopropylamino)ethyl]methanesulfonanilide Hydrochloride
135. Sotalol Hydrochloride, United States Pharmacopeia (usp) Reference Standard
136. N-(4-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}phenyl)methanesulfonamide Hydrochloride
137. N-[4-[1-oxidanyl-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide Hydrochloride
138. Methanesulfonamide, N-(4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)-, Hydrochloride (1:1)
Molecular Weight | 308.83 g/mol |
---|---|
Molecular Formula | C12H21ClN2O3S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 6 |
Exact Mass | 308.0961414 g/mol |
Monoisotopic Mass | 308.0961414 g/mol |
Topological Polar Surface Area | 86.8 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 330 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Betapace |
PubMed Health | Sotalol (By mouth) |
Drug Classes | Antianginal, Antiarrhythmic, Group III, Cardiovascular Agent |
Drug Label | Betapace AF, (sotalol hydrochloride), is an antiarrhythmic drug with Class II (beta-adrenoreceptor blocking) and Class III (cardiac action potential duration prolongation) properties. It is supplied as a white, capsule-shaped tablet for oral administ... |
Active Ingredient | Sotalol hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 160mg; 120mg; 80mg; 240mg |
Market Status | Prescription |
Company | Bayer Hlthcare |
2 of 6 | |
---|---|
Drug Name | Betapace af |
PubMed Health | Sotalol |
Drug Classes | Antianginal, Antiarrhythmic, Group III, Cardiovascular Agent |
Drug Label | Betapace AF, (sotalol hydrochloride), is an antiarrhythmic drug with Class II (beta-adrenoreceptor blocking) and Class III (cardiac action potential duration prolongation) properties. It is supplied as a white, capsule-shaped tablet for oral administ... |
Active Ingredient | Sotalol hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 160mg; 120mg; 80mg |
Market Status | Prescription |
Company | Bayer Hlthcare |
3 of 6 | |
---|---|
Drug Name | Sotalol hydrochloride |
Drug Label | Sotalol hydrochloride tablets (AF) are an antiarrhythmic drug with Class II (beta-adrenoreceptor blocking) and Class III (cardiac action potential duration prolongation) properties. The 80 mg, 120 mg and 160 mg strengths are supplied as light-orange,... |
Active Ingredient | Sotalol hydrochloride |
Dosage Form | Tablet; Solution |
Route | Oral; Intravenous |
Strength | 150mg/10ml (15mg/ml); 160mg; 120mg; 80mg; 240mg |
Market Status | Prescription |
Company | Vintage Pharms; Impax Pharms; Epic Pharma; Teva; Apotex; Sandoz; Academic Pharms; Mylan |
4 of 6 | |
---|---|
Drug Name | Betapace |
PubMed Health | Sotalol (By mouth) |
Drug Classes | Antianginal, Antiarrhythmic, Group III, Cardiovascular Agent |
Drug Label | Betapace AF, (sotalol hydrochloride), is an antiarrhythmic drug with Class II (beta-adrenoreceptor blocking) and Class III (cardiac action potential duration prolongation) properties. It is supplied as a white, capsule-shaped tablet for oral administ... |
Active Ingredient | Sotalol hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 160mg; 120mg; 80mg; 240mg |
Market Status | Prescription |
Company | Bayer Hlthcare |
5 of 6 | |
---|---|
Drug Name | Betapace af |
PubMed Health | Sotalol |
Drug Classes | Antianginal, Antiarrhythmic, Group III, Cardiovascular Agent |
Drug Label | Betapace AF, (sotalol hydrochloride), is an antiarrhythmic drug with Class II (beta-adrenoreceptor blocking) and Class III (cardiac action potential duration prolongation) properties. It is supplied as a white, capsule-shaped tablet for oral administ... |
Active Ingredient | Sotalol hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 160mg; 120mg; 80mg |
Market Status | Prescription |
Company | Bayer Hlthcare |
6 of 6 | |
---|---|
Drug Name | Sotalol hydrochloride |
Drug Label | Sotalol hydrochloride tablets (AF) are an antiarrhythmic drug with Class II (beta-adrenoreceptor blocking) and Class III (cardiac action potential duration prolongation) properties. The 80 mg, 120 mg and 160 mg strengths are supplied as light-orange,... |
Active Ingredient | Sotalol hydrochloride |
Dosage Form | Tablet; Solution |
Route | Oral; Intravenous |
Strength | 150mg/10ml (15mg/ml); 160mg; 120mg; 80mg; 240mg |
Market Status | Prescription |
Company | Vintage Pharms; Impax Pharms; Epic Pharma; Teva; Apotex; Sandoz; Academic Pharms; Mylan |
Adrenergic beta-Antagonists
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Sympatholytics
Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?